blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0707581

EP0707581 - INDOLINE DERIVATIVES AS 5HT2C ANTAGONISTS [Right-click to bookmark this link]
Former [1996/17]INDOLINE DERIVATIVES AS 5HT 2C? ANTAGONISTS
[1997/09]
StatusNo opposition filed within time limit
Status updated on  24.12.1997
Database last updated on 13.07.2024
Most recent event   Tooltip09.05.2002Lapse of the patent in a contracting state
New state(s): ES
published on 26.06.2002  [2002/26]
Applicant(s)For all designated states
SMITHKLINE BEECHAM PLC
New Horizons Court Brentford
Middlesex TW8 9EP / GB
[N/P]
Former [1996/17]For all designated states
SMITHKLINE BEECHAM PLC
New Horizons Court
Brentford, Middlesex TW8 9EP / GB
Inventor(s)01 / HAM, Peter, SmithKline Beecham Pharmaceuticals
Coldharbour Road, The Pinnacles
Harlow, Essex CM19 5AD / GB
02 / JONES, Graham Elgin, SmithKline Beecham Pharm.
Coldharbour Road, The Pinnacles
Harlow, Essex CM19 5AD / GB
03 / FORBES, Ian Thomson, SmithKline Beecham Pharmac.
Coldharbour Road, The Pinnacles
Harlow, Essex CM19 5AD / GB
[1997/09]
Former [1996/17]01 / HAM, Peter, SmithKline Beecham Pharmaceuticals
Coldharbour Road, The Pinnacles
Harlow, Essex CM19 5AD / GB
02 / JONES, Graham Elgin, SmithKline Beecham Pharm.
Coldharbour Road, The Pinnacles
Harlow, EssexCM19 5A D / GB
03 / FORBES, Ian Thomson, SmithKline Beecham Pharmac.
Coldharbour Road, The Pinnacles
Harlow, EssexCM19x 5AD / GB
Representative(s)Waters, David Martin, et al
GlaxoSmithKline Corporate Intellectual Property (CN9.25.1) 980 Great West Road
Brentford, Middlesex TW8 9GS / GB
[N/P]
Former [1997/14]Waters, David Martin, Dr., et al
Smithkline Beecham plc Corporate Intellectual Property, Two New Horizons Court
Brentford, Middlesex TW8 9EP / GB
Former [1996/17]Summersell, Richard John, et al
SmithKline Beecham Corporate Intellectual Property SB House Great West Road
Brentford, Middlesex TW8 9BD / GB
Application number, filing date94921638.630.06.1994
[1996/17]
WO1994EP02148
Priority number, dateGB1993001391306.07.1993         Original published format: GB 9313913
[1996/17]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO9501976
Date:19.01.1995
Language:EN
[1995/04]
Type: A1 Application with search report 
No.:EP0707581
Date:24.04.1996
Language:EN
The application published by WIPO in one of the EPO official languages on 19.01.1995 takes the place of the publication of the European patent application.
[1996/17]
Type: B1 Patent specification 
No.:EP0707581
Date:26.02.1997
Language:EN
[1997/09]
Search report(s)International search report - published on:EP19.01.1995
ClassificationIPC:C07D401/12, A61K31/40, C07D413/12, C07D409/14
[1996/17]
CPC:
C07D401/12 (EP,US); A61P1/14 (EP); A61P25/00 (EP);
A61P25/26 (EP); A61P25/28 (EP); A61P43/00 (EP);
C07D413/12 (EP,US) (-)
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [1996/17]
Extension statesSI28.12.1995
TitleGerman:INDOLIN DERIVATE ALS 5HT2C ANTAGONISTEN[1997/09]
English:INDOLINE DERIVATIVES AS 5HT2C ANTAGONISTS[1997/09]
French:DERIVES INDOLINIQUES UTILISES COMME ANTAGONISTES DE 5HT2C[1997/09]
Former [1996/17]INDOLIN DERIVATE ALS 5 HT2C ANTAGONISTEN
Former [1996/17]INDOLINE DERIVATIVES AS 5HT 2C? ANTAGONISTS
Former [1996/17]DERIVES INDOLINIQUES UTILISES COMME ANTAGONISTES DE 5HT 2C?
Entry into regional phase28.12.1995National basic fee paid 
28.12.1995Designation fee(s) paid 
28.12.1995Examination fee paid 
Examination procedure31.01.1995Request for preliminary examination filed
International Preliminary Examining Authority: EP
28.12.1995Examination requested  [1996/17]
17.07.1996Despatch of communication of intention to grant (Approval: Yes)
21.08.1996Communication of intention to grant the patent
21.11.1996Fee for grant paid
21.11.1996Fee for publishing/printing paid
Opposition(s)27.11.1997No opposition filed within time limit [1998/07]
Fees paidRenewal fee
07.06.1996Renewal fee patent year 03
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT26.02.1997
DK26.02.1997
ES26.02.1997
GR26.02.1997
PT26.05.1997
SE26.05.1997
IE30.06.1997
LU30.06.1997
[2002/26]
Former [2001/01]AT26.02.1997
DK26.02.1997
GR26.02.1997
PT26.05.1997
SE26.05.1997
IE30.06.1997
LU30.06.1997
Former [2000/05]AT26.02.1997
DK26.02.1997
GR26.02.1997
PT26.05.1997
SE26.05.1997
LU30.06.1997
Former [1998/15]AT26.02.1997
DK26.02.1997
PT26.05.1997
SE26.05.1997
Former [1998/11]AT26.02.1997
PT26.05.1997
SE26.05.1997
Former [1998/03]AT26.02.1997
PT26.05.1997
Former [1997/42]AT26.02.1997
Cited inInternational search[X]US4428881  (HEDRICH LOREN W [US], et al) [X] 1 * column 1, table, first half *;
 [A]WO9205170  (BEECHAM GROUP PLC [GB]) [A] 1,8 * claim - *;
 [DPA]WO9404533  (SMITHKLINE BEECHAM PLC [GB], et al) [DPA] 1,8* claim - *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.